A detailed history of Bellevue Group Ag transactions in Generation Bio Co. stock. As of the latest transaction made, Bellevue Group Ag holds 3,918,856 shares of GBIO stock, worth $8.66 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,918,856
Previous 3,861,575 1.48%
Holding current value
$8.66 Million
Previous $15.7 Million 29.68%
% of portfolio
0.18%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.64 - $4.35 $151,221 - $249,172
57,281 Added 1.48%
3,918,856 $11.1 Million
Q1 2024

May 15, 2024

BUY
$1.73 - $4.07 $422,976 - $995,094
244,495 Added 6.76%
3,861,575 $15.7 Million
Q3 2023

Nov 14, 2023

SELL
$3.65 - $6.9 $11,680 - $22,080
-3,200 Reduced 0.09%
3,617,080 $13.7 Million
Q1 2023

May 15, 2023

SELL
$3.61 - $7.01 $25,270 - $49,070
-7,000 Reduced 0.19%
3,620,280 $15.6 Million
Q2 2022

Aug 11, 2022

SELL
$4.87 - $9.41 $267,363 - $516,609
-54,900 Reduced 1.49%
3,627,280 $23.8 Million
Q1 2022

May 13, 2022

SELL
$4.16 - $7.76 $790,400 - $1.47 Million
-190,000 Reduced 4.91%
3,682,180 $27 Million
Q4 2021

Feb 10, 2022

BUY
$5.99 - $24.97 $8.39 Million - $35 Million
1,400,000 Added 56.63%
3,872,180 $27.4 Million
Q3 2021

Nov 12, 2021

SELL
$20.0 - $27.43 $120,000 - $164,580
-6,000 Reduced 0.24%
2,472,180 $62 Million
Q2 2021

Aug 12, 2021

BUY
$24.34 - $38.34 $2.07 Million - $3.26 Million
85,000 Added 3.55%
2,478,180 $66.7 Million
Q1 2021

May 12, 2021

BUY
$24.74 - $40.2 $1.48 Million - $2.41 Million
60,000 Added 2.57%
2,393,180 $68.1 Million
Q4 2020

Feb 16, 2021

BUY
$21.68 - $51.61 $9.82 Million - $23.4 Million
453,180 Added 24.11%
2,333,180 $66.1 Million
Q3 2020

Nov 16, 2020

BUY
$18.07 - $31.84 $7.95 Million - $14 Million
440,000 Added 30.56%
1,880,000 $58.1 Million
Q2 2020

Aug 13, 2020

BUY
$20.1 - $24.69 $28.9 Million - $35.6 Million
1,440,000 New
1,440,000 $30.2 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $130M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.